Please use this identifier to cite or link to this item: https://doi.org/10.1002/jha2.618
DC FieldValue
dc.titleProcoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study.
dc.contributor.authorYap, Eng Soo
dc.contributor.authorLijfering, Willem M
dc.contributor.authorTimp, Jasmijn F
dc.contributor.authorRosendaal, Frits R
dc.contributor.authorCannegieter, Suzanne C
dc.contributor.authorScheres, Luuk JJ
dc.date.accessioned2023-03-03T04:16:18Z
dc.date.available2023-03-03T04:16:18Z
dc.date.issued2023-02
dc.identifier.citationYap, Eng Soo, Lijfering, Willem M, Timp, Jasmijn F, Rosendaal, Frits R, Cannegieter, Suzanne C, Scheres, Luuk JJ (2023-02). Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study.. EJHaem 4 (1) : 3-12. ScholarBank@NUS Repository. https://doi.org/10.1002/jha2.618
dc.identifier.issn26886146
dc.identifier.issn26886146
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/237845
dc.description.abstractPatients with venous thrombosis (VT) are at increased risk of future arterial cardiovascular disease (CVD) (i.e., myocardial infarction, ischemic stroke or peripheral artery disease). We investigated whether shared risk factors for VT and CVD are associated with the levels of procoagulant factors (fibrinogen, factor VIII, and von Willebrand factor), and whether the relationship between these risk factors and subsequent CVD was mediated through these procoagulant factors in patients with VT. In a follow-up study consisting of 4956 patients with VT, 2176 patients (44%) provided blood samples and were linked to the Dutch Hospital registry of Statistics Netherlands to identify hospital admissions or procedures for subsequent CVD. In total, 52 CVD events occurred over a follow-up of 11,124 years, with an incidence rate of 4.7 per 1000 patient years (95% confidence intervals 3.5-6.1). Increasing age, male sex, smoking history, major illnesses, dyslipidemia, and impaired fasting glucose levels were associated with increased CVD risk. Procoagulant factor levels were also associated with CVD risk. When adjusted for these procoagulant factors, the association between the risk factors and CVD attenuated partially. This study provides evidence that procoagulant factors can partially explain the association between increased risks of subsequent CVD in patients with previous VT.
dc.publisherWiley
dc.sourceElements
dc.subjectcardiovascular disease
dc.subjectcoagulation factors
dc.subjectepidemiology
dc.subjectrisk factors
dc.subjectvenous thrombosis
dc.typeArticle
dc.date.updated2023-03-03T03:26:05Z
dc.contributor.departmentMEDICINE
dc.description.doi10.1002/jha2.618
dc.description.sourcetitleEJHaem
dc.description.volume4
dc.description.issue1
dc.description.page3-12
dc.published.stateUnpublished
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis A cohort st.pdf281.04 kBAdobe PDF

OPEN

PublishedView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.